ATCC® Human Pluripotent Stem Cells

Enabling Research through Standards

8/21/2014


Induced pluripotent stem cells (iPSCs) provide a powerful tool to model human disease in relevant cell types. iPSCs may be generated from patients of any genetic background, and possess the capacity to differentiate into almost any desired terminal cell type. In this webinar, we will focus on ATCC's approach in generating and providing standardized, quality controlled, and highly characterized human iPSCs lines with its complete culture systems. We will also highlight the characterization of LRRK2 Parkinson’s patient-derived iPSC lines by whole-exome sequencing.

Presenters

Yukari Tokuyama, Ph.D.

Yukari Tokuyama, Ph.D.,
Field Application Scientist, ATCC